Regulation of the dopamine transporter - Addiction Research ...

Schmitt & Reith DAT Regulation
24. Chi, L. & M.E. Reith. 2003. Substrate-induced trafficking
of the dopamine transporter in heterologously
expressing cells and in rat striatal synaptosomal preparations.
J. Pharmacol. Exp. Ther. 307: 729–736.
25. Sorkina, T., S. Doolen, E. Galperin, et al. 2003.
Oligomerization of dopamine transporters visualized
in living cells by fluorescence resonance energy transfer
microscopy. J. Biol. Chem. 278: 28274–28283.
26. Sorkina, T., B.R. Hoover, N.R. Zahniser & A. Sorkin.
2005. Constitutive and protein kinase C-induced internalization
of the dopamine transporter is mediated
by a clathrin-dependent mechanism. Traffic 6: 157–
170.
27. Chen, N. & M.E. Reith. 2008. Substrates dissociate
dopamine transporter oligomers. J. Neurochem. 105:
910–920.
28. Gulley, J.M., S. Doolen & N.R. Zahniser. 2002.
Brief, repeated exposure to substrates down-regulates
dopamine transporter function in Xenopus oocytes in
vitro and rat dorsal striatum in vivo. J. Neurochem. 83:
400–411.
29. Kahlig, K.M., J. Javitch & A. Galli. 2004. Amphetamine
regulation of dopamine transport. Combined measurements
of transporter currents and transporter imaging
support the endocytosis of an active carrier. J. Biol.
Chem. 279: 8966–8975.
30. Richards, T.L. & N.R. Zahniser. 2009. Rapid substrateinduced
down-regulation in function and surface localization
of dopamine transporters: rat dorsal striatum
versus nucleus accumbens. J. Neurochem. 108: 1575–
1584.
31.Johnson,L.A.,C.A.Furman,M.Zhang,et al. 2005.
Rapid delivery of the dopamine transporter to the plasmalemmal
membrane upon amphetamine stimulation.
Neuropharmacology 49: 750–758.
32. Furman, C.A., R. Chen, B. Guptaroy, et al.
2009. Dopamine and amphetamine rapidly increase
dopamine transporter trafficking to the surface: livecell
imaging using total internal reflection fluorescence
microscopy. J. Neurosci. 29: 3328–3336.
33. Das, G. 1993. Cocaine abuse in North America: a milestone
in history. J. Clin. Pharmacol. 33: 296–310.
34. Loland, C., R.I. Desai, M.F. Zou, et al. 2008. Relationship
between conformational changes in the dopamine
transporter and cocaine-like subjective effects of uptake
inhibitors. Mol. Pharmacol. 73: 813–823.
35. Schmitt, K.C., J. Zhen, P. Kharkar, et al. 2008. Interaction
of cocaine-, benztropine- and GBR12909like
compounds with wild-type and mutant human
dopamine transporters: molecular features that dif-
ferentially determine antagonist-binding properties. J.
Neurochem. 107: 928–940.
36. Kahlig, K.M. & A. Galli. 2003. Regulation of dopamine
transporter function and plasma membrane expression
by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol.
479: 153–158.
37. Beveridge, T.J., H.R. Smith, M.A. Nader & L.J. Porrino.
2009. Abstinence from chronic cocaine selfadministration
alters striatal dopamine systems in
rhesus monkeys. Neuropsychopharmacology 34: 1162–
1171.
38. Little,K.Y.,L.Zhang,T.Desmond,et al. 1999. Striatal
dopaminergic abnormalities in human cocaine users.
Am.J.Psychiatry156: 238–245.
39. Mash, D.C., J. Pablo, Q. Ouyang, et al. 2002. Dopamine
transport function is elevated in cocaine users. J. Neurochem.
81: 292–300.
40. Oleson, E.B., S. Talluri, S.R. Childers, et al. 2009.
Dopamine uptake changes associated with cocaine selfadministration.
Neuropsychopharmacology 34: 1174–
1184.
41. Negus, S.S. & N.K. Mello. 2003. Effects of chronic
d-amphetamine treatment on cocaine- and foodmaintained
responding under a second-order schedule
in rhesus monkeys. Drug. Alcohol Dep. 70: 39–52.
42. Grabowski, J., J. Shearer, J. Merrill & S.S. Negus. 2004.
Agonist-like, replacement pharmacotherapy for stimulant
abuse and dependence. Addict. Behav. 29: 1439–
1464.
43. Castells, X., M. Casas, X. Vidal, et al. 2007. Efficacy of
central nervous system stimulant treatment for cocaine
dependence: a systematic review and meta-analysis of
randomized controlled clinical trials. Addiction 102:
1871–1887.
44. Rush, C.R., W.W. Stoops & L.R. Hays. 2009. Cocaine
effects during d-amphetamine maintenance: A. Human
laboratory analysis of safety, tolerability and efficacy.
Drug. Alcohol Dep. 99: 261–271.
45. Cervinski, M.A., J.D. Foster & R.A. Vaughan. 2005. Psychoactive
substrates stimulate dopamine transporter
phosphorylation and down-regulation by cocainesensitive
and protein kinase C-dependent mechanisms.
J. Biol. Chem. 49: 40442–40449.
46. Daws, L.C., P.D. Callaghan, J.A. Morón, et al. 2002.
Cocaine increases dopamine uptake and cell surface
expression of dopamine transporters. Biochem. Biophys.
Res. Commun. 290: 1545–1550.
47. Little, K.Y., L.W. Elmer, H. Zhong, et al. 2002. Cocaine
induction of dopamine transporter trafficking to the
plasma membrane. Mol. Pharmacol. 61: 436–445.
Ann. N.Y. Acad. Sci. 1187 (2010) 316–340 c○ 2010 New York Academy of Sciences. 335